Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Polyglutamate Levels as a Marker for Clinical Outcome in Rheumatoid Arthritis
NCT00695188Phase 4Completed
- Sponsor
- Ludwig-Boltzmann-Institut für Rheumatologie, Balneologie und Rehabilitation
- Start
- May 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by Ludwig-Boltzmann-Institut für Rheumatologie, Balneologie und Rehabilitation. Primary endpoint: Disease Activity Score in 28 Joints at 16 weeks. Started May 2008; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00695188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695188.